ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      66,891.64
      -0.28%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Bone Therapeutics Sa (0R55)

      7. Bone Therapeutics Sa (0R55) News

      0R55

      Bone Therapeutics (0R55)

      Bone Therapeutics Sa
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:0R55
      DateTimeSourceHeadlineSymbolCompany
      03/20/20242:00AMUK RegulatoryBioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémiqueLSE:0R55Bone Therapeutics Sa
      03/20/20242:00AMUK RegulatoryBioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World CongressLSE:0R55Bone Therapeutics Sa
      03/12/20242:00AMUK RegulatoryBioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3LSE:0R55Bone Therapeutics Sa
      03/12/20242:00AMUK RegulatoryBioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host diseaseLSE:0R55Bone Therapeutics Sa
      02/29/20241:00AMUK RegulatoryBioSenic S.A. : Information relative au nombre total de droits de vote et d’actionsLSE:0R55Bone Therapeutics Sa
      02/29/20241:00AMUK RegulatoryBioSenic S.A. : Information on the total number of voting rights and sharesLSE:0R55Bone Therapeutics Sa
      02/02/202411:30AMUK RegulatoryBioSenic lève 500 000 euros dans le cadre d'un placement privé d'actions nouvelles auprès de nouveaux investisseurs établisLSE:0R55Bone Therapeutics Sa
      02/02/202411:30AMUK RegulatoryBioSenic raises €500,000 in private placement of new shares with established new investorsLSE:0R55Bone Therapeutics Sa
      01/31/20244:30AMUK RegulatoryBioSenic soutient la prochaine conférence européenne sur la maladie du greffon contre l'hôteLSE:0R55Bone Therapeutics Sa
      01/31/20244:30AMUK RegulatoryBioSenic provides support to forthcoming European conference on graft-versus-host disease  LSE:0R55Bone Therapeutics Sa
      01/30/20241:00AMUK RegulatoryLe brevet de BioSenic est accordé au Canada pour une protection plus large de sa plate-forme thérapeutique ATOLSE:0R55Bone Therapeutics Sa
      01/30/20241:00AMUK RegulatoryBioSenic patent granted in Canada for broader protection of ATO therapeutic platformLSE:0R55Bone Therapeutics Sa
      01/25/20241:00AMUK RegulatoryBioSenic présente de nouvelles données de phase 3 sur JTA-004 pour le traitement de la douleur arthrosique sévère lors du congrès mondial de l'OARSI 2024LSE:0R55Bone Therapeutics Sa
      01/25/20241:00AMUK RegulatoryBioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World CongressLSE:0R55Bone Therapeutics Sa
       Showing the most relevant articles for your search:LSE:0R55